The molecular diagnostic is a method which is used to identify and examine nucleic acids or proteins at a molecular level. This method is used to evaluate the genetic makeup to an individual to identify predisposition to a particular disease to condition and detect it. This method is mainly used to diagnose disease and risk occurred. It also mainly used to decide the therapies which are suitable for the individual patients.
|Market||Molecular Diagnostics Market|
|Analysis Period||2015 - 2026|
|Forecast Data||2015 - 2026|
|Segments Covered||By Product, By Technology, By Application, By End-User and By Geography|
|Regional Scope||North America, Europe, Asia Pacific, Latin America, and Middle East & Africa|
|Key Companies Profiled||Abbott Molecular Cepheid, BioMerieux’s, Roche diagnostics ,Danaher Corporation, Siemens Healthcare, Qiagen Gaithersburg ,Johnson and Johnson ,Agilent (Dako), GenMark diagnostics, Analytik Jena and Alere Inc.|
||Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis|
|Customization Scope||10 hrs of free customization and expert consultation|
Growing prevalence of infectious diseases & cancers, rising awareness and acceptance of personalized medicines, increase in the biomarker identification, and improvement in molecular diagnostics are some of the major factors driving the growth of the market. Additionally, technological advancement in molecular diagnostics is also responsible to drive the market, as they provide greater accuracy, portability, and cost effectiveness. Moreover, rise in funding by governments and various organizations in the clinical studies in the molecular diagnosis space is expected to propel the growth of the market. Increasing geriatric population is also one of the major factor boosting the growth of the market.
However, stringent regulatory necessities for the approval of recent molecular diagnostics methods are some of the restraining factors hampering the growth of the market. Additionally, the market consists of several opportunities such as rising adoption of the molecular diagnostics in the developing economies.
Market Classification and Overview
The global molecular diagnostics market is segmented into product, technology, application, end-user, and region.
On the basis of product, the market is segmented into instruments, reagents, software & services.
On the basis of technology, the market is segmented into polymerase chain reactions (pcr), hybridization, DNA sequencing, microarray, and others.
Based on the application, the market is segmented into infectious diseases, oncology, genetic testing, blood screening, and others
On the basis of end-user, the market is segmented into hospitals, laboratories, and others.
Geographically, the global molecular diagnostics market is bifurcated into four regions such as North America, Europe, Asia Pacific (APAC), and Latin America, Middle East & Africa (LAMEA).
North America is expected to be the largest region during the forecast period 2018-2026 owing to the presence of well-established diagnostic infrastructure and technological improvements in the field of molecular diagnostics.
Asia Pacific is expected to drive significantly during the forecasted period owing to the presence of large targeted population and high unmet clinical needs. Moreover, the increasing government initiatives in the countries such as India and China, to develop health infrastructure us likely to propel the growth of the market in this region.
Europe is expected to hold the major share during the forecast period 2018-2026 owing to the rising incidences of lifestyles and infectious diseases attached with favorable demographic trend such as geriatric population. Growing awareness regarding the advantages of early diagnostics is further likely to propel the growth of the market in this region.
LAMEA is expected to witness a steady growth during the forecasted period due to the lack of knowledge and poor infrastructure development.
The molecular diagnostics market comprises of some of the major players such as
For instance, in November 2017, Hummingbird Diagnostics GmbH and Saarland University collaborated in early disease detection based on molecular markers.
Market By Product
Market By Technology
Market By Application
Market By End-User
Market By Geography